Palumbo Wealth Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Palumbo Wealth Management’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Hold	4,000	–	–	0.08%	163
2026 Q1	$326K	Hold	4,000	–	–	0.08%	162
2025 Q4	$319K	Sell	4,000 -8,851	-69%	-$655K	0.08%	164
2025 Q3	$238K	Buy	+12,851	New	+$692K	0.08%	161
2025 Q1	–	Sell	-4,000	Closed	-$203K	–	188
2024 Q4	$203K	Hold	4,000	–	–	0.08%	152
2024 Q3	$255K	Hold	4,000	–	–	0.1%	122
2024 Q2	$237K	Hold	4,000	–	–	0.1%	118
2024 Q1	$230K	Hold	4,000	–	–	0.1%	115
2023 Q4	$228K	Buy	+4,000	New	+$188K	0.12%	111
2023 Q3	–	Sell	-4,000	Closed	-$208K	–	117
2023 Q2	$208K	Hold	4,000	–	–	0.13%	102
2023 Q1	$217K	Buy	+4,000	New	+$226K	0.14%	88

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Palumbo Wealth Management's BIB Position: Q2 2026 in Review

Palumbo Wealth Management held its ProShares Ultra NASDAQ Biotechnology (BIB) position steady in Q2 2026 at 4,000 shares worth $403K. The position accounts for 0.08% of the portfolio, ranked #163.

Palumbo Wealth Management first reported a position in BIB in Q1 2023 and has held it in 11 quarters since. 20 funds tracked by Wall St. Rank hold BIB as of Q2 2026.

Palumbo Wealth Management held 4,000 shares of ProShares Ultra NASDAQ Biotechnology worth $403K as of Q2 2026.
Palumbo Wealth Management left its ProShares Ultra NASDAQ Biotechnology share count unchanged in Q2 2026.
ProShares Ultra NASDAQ Biotechnology made up 0.08% of Palumbo Wealth Management's portfolio in Q2 2026, its #163 holding.
Palumbo Wealth Management first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2023 and has held it in 11 quarters since.
20 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.